Web-Books
in the Austria-Forum
Austria-Forum
Web-Books
Medizin
Advances in Neuroimmunology
Page - 41 -
  • User
  • Version
    • full version
    • text only version
  • Language
    • Deutsch - German
    • English

Page - 41 - in Advances in Neuroimmunology

Image of the Page - 41 -

Image of the Page - 41 - in Advances in Neuroimmunology

Text of the Page - 41 -

BrainSci. 2016,6, 6 70. Belarbi,K.; Jopson,T.; Tweedie,D.;Arellano,C.; Luo,W.;Greig,N.H.; Rosi, S. TNF-αprotein synthesis inhibitor restoresneuronal functionandreversescognitivedeficits inducedbychronicneuroinflammation. J.Neuroinflamm. 2012,9, 23. [CrossRef] [PubMed] 71. Marousi,S.;Antonacopoulou,A.;Kalofonos,H.;Papathanasopoulos,P.;Karakantza,M.;Ellul, J.Functional inflammatory genotypes in ischemic stroke: Couldweuse them topredict age of onset and long-term outcome?StrokeRes. Treat. 2011,2011, 792923. [CrossRef] [PubMed] 72. Klein, B.D.; White,H.S.; Callahan, K.S. Cytokine and intracellular signaling regulation of tissue factor expression inastrocytes.Neurochem. Int. 2000,36, 441–449. [CrossRef] 73. Tsoi,L.-M.;Wong,K.-Y.;Liu,Y.-M.;Ho,Y.-Y.ApoproteinE isoform-dependentexpressionandsecretionof pro-inflammatorycytokinesTNF-alphaandIL-6 inmacrophages.Arch. Biochem.Biophys. 2007,460, 33–40. [CrossRef] [PubMed] 74. Lull,M.E.; Block,M.L.Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010, 7, 354–365. [CrossRef] [PubMed] 75. Barichello,T.;dosSantos, I.; Savi,G.D.;Simões,L.R.;Silvestre,T.;Comim,C.M.;Sachs,D.;Teixeira,M.M.; Teixeira,A.L.;Quevedo, J. TNF-α, IL-1β, IL-6, andcinc-1 levels in rat brainaftermeningitis inducedby Streptococcuspneumoniae. J.Neuroimmunol. 2010,221, 42–45. [CrossRef] [PubMed] 76. Liu,T.;Clark,R.K.;McDonnell,P.C.;Young,P.R.;White,R.F.;Barone,F.C.;Feuerstein,G.Z.Tumornecrosis factor-alphaexpression in ischemicneurons.Stroke1994,25, 1481–1488. [CrossRef] [PubMed] 77. Batti, L.; O’Connor, J.J. Tumornecrosis factor-alpha impairs the recoveryof synaptic transmission from hypoxia inrathippocampalslices. J.Neuroimmunol. 2010,218, 21–27. [CrossRef] [PubMed] 78. O’Connor, J.J.Targeting tumournecrosis factor-α inhypoxiaandsynaptic signaling. Ir. J.Med. Sci. 2013,182, 157–162. [CrossRef] [PubMed] 79. Hindryckx,P.;DeVos,M.; Jacques,P.; Ferdinande,L.; Peeters,H.;Olievier,K.; Bogaert, S.; Brinkman,B.; Vandenabeele,P.;Elewaut,D.Hydroxylase inhibitionabrogatesTNF-α-induced intestinalepithelialdamage byhypoxia-inducible factor-1-dependent repressionofFADD. J. Immunol. 2010,185, 6306–6316. [CrossRef] [PubMed] 80. Rosenzweig,H.L.;Minami,M.;Lessov,N.S.;Coste,S.C.; Stevens,S.L.;Henshall,D.C.;Meller,R.; Simon,R.P.; Stenzel-Poore,M.P.Endotoxinpreconditioningprotectsagainst thecytotoxiceffectsofTNFαafterstroke: A novel role for TNFalpha in LPS-ischemic tolerance. J. Cereb Blood FlowMetab. 2007, 27, 1663–1674. [CrossRef] [PubMed] 81. Fan,H.;Cook,J.A.Molecularmechanismsofendotoxintolerance. J.EndotoxinRes.2004,10,71–84. [CrossRef] [PubMed] 82. Stetler, R.A.; Leak, R.K.; Gan, Y.; Li, P.; Zhang, F.; Hu, X.; Jing, Z.; Chen, J.; Zigmond, M.J.; Gao, Y. Preconditioningprovidesneuroprotection inmodelsofCNSdisease: Paradigmsandclinical significance. Prog.Neurobiol. 2014,114, 58–83. [CrossRef] [PubMed] 83. Bastide,M.;Gelé,P.;Pétrault,O.;Pu,Q.;Caliez,A.;Robin,E.;Deplanque,D.;Duriez,P.;Bordet,R.Delayed cerebrovascularprotectiveeffectof lipopolysaccharide inparallel tobrain ischemic tolerance. J.Cereb. Blood FlowMetab. 2003,23, 399–405. [CrossRef] [PubMed] 84. Karikó,K.;Weissman,D.;Welsh,F.A. Inhibitionof toll-like receptorandcytokinesignaling—Aunifying themein ischemic tolerance. J.Cereb. BloodFlowMetab. 2004,24, 1288–1304. [CrossRef] [PubMed] 85. Lastres-Becker, I.;Cartmell,T.;Molina-Holgado,F.Endotoxinpreconditioningprotectsneuronesfrom invitro ischemia: Roleof endogenous IL-1betaandTNF-alpha. J.Neuroimmunol. 2006,173, 108–116. [CrossRef] [PubMed] 86. Pickering, M.; O’Connor, J.J. Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog. BrainRes.2007,163, 339–354. [PubMed] 87. Cumiskey,D.;Butler,M.P.;Moynagh,P.N.;O’Connor, J.J.Evidenceforarole for thegroupImetabotropic glutamatereceptor intheinhibitoryeffectof tumornecrosis factor-alphaonlong-termpotentiation.BrainRes. 2007,1136, 13–19. [CrossRef] [PubMed] 88. Butler,M.P.;O’Connor, J.J.;Moynagh,P.N.Dissectionof tumor-necrosis factor-alpha inhibitionof long-term potentiation(LTP)revealsap38mitogen-activatedproteinkinase-dependentmechanismwhichmapsto early-butnot late-phaseLTP.Neuroscience2004,124, 319–326. [CrossRef] [PubMed] 41
back to the  book Advances in Neuroimmunology"
Advances in Neuroimmunology
Title
Advances in Neuroimmunology
Author
Donna Gruol
Editor
MDPI
Location
Basel
Date
2017
Language
English
License
CC BY-NC-ND 4.0
ISBN
978-3-03842-571-7
Size
17.0 x 24.0 cm
Pages
164
Keywords
neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
Category
Medizin
Web-Books
Library
Privacy
Imprint
Austria-Forum
Austria-Forum
Web-Books
Advances in Neuroimmunology